Nachrichten zur Bristol-Myers Squibb Co Aktie

How Will Bristol Myers Squibb Stock Trend Post Q4 Results?

A decline in Revlimid sales will likely more than offset sales growth for Eliquis, Opdivo, and Reblozyl....…

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol Myers Squibb (BMY) closed at $72.45 in the latest trading session, marking a -0.74% move from the prior day....…

Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY

Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY...…

Bristol Myers wins EU backing to expand label for anemia therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More

DUBLIN, Jan. 26, 2023 /PRNewswire/ -- The "Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key…

iVexSol closes $23.8M series A-3 financing by Bristol Myers Squibb, Charles River, Asahi Kasei

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Preview: Bristol Myers Squibb (BMY) Q4 Earnings Expected to Decline

Bristol Myers (BMY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

OstoBuddy and South Asian IBD Alliance Named Winners of Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease

PRINCETON, N.J., Jan. 26, 2023 /PRNewswire/ -- Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation,…

Bristol-Myers earns bullish views at Cantor on breakout potential

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb Wins Another Approval for Its Multimillion-Dollar Cancer Drug

A cutting-edge cancer treatment from the drugmaker was recently approved in Japan to treat a type of lymphoma....…

The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Honeywell, Sony, Airbnb and Republic Services

Bristol-Myers Squibb, Honeywell, Sony, Airbnb and Republic Services are included in this Analyst Blog....…

Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Outlook on the Nasopharyngeal Cancer Global Market to 2028 - Featuring Biocon, Bristol-Myers Squibb, Cyclacel Pharmaceuticals and Eli Lilly and Co Among Others

DUBLIN, Jan. 9, 2023 /PRNewswire/ -- The "Global Nasopharyngeal Cancer Market Research and Forecast, 2022-2028" report has been added to…

Schrödinger inks drug discovery licensing deals with Bristol Myers, Otsuka

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Dragonfly Therapeutics gibt das sechste Dragonfly TriNKET Opt-in von Bristol Myers Squibb bekannt

Dragonfly Therapeutics, Inc.: Waltham, Massachusetts (ots/PRNewswire) - Seit ihrer ursprünglichen Zusammenarbeit im Jahr 2017, die sich auf hämatologische Malignitäten konzentrierte,…

Dragonfly Therapeutics gibt das sechste Dragonfly TriNKET Opt-in von Bristol Myers Squibb bekannt

Seit ihrer ursprünglichen Zusammenarbeit im Jahr 2017, die sich auf hämatologische Malignitäten konzentrierte, haben die Unternehmen zwei zusätzliche Kooperationen vereinbart,…

Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring…

Dragonfly Therapeutics Announces Sixth Dragonfly TriNKET Opt-in by Bristol Myers Squibb

Since their original 2017 collaboration focusing on hematology malignancies, the companies have agreed to two additional collaborations which include oncology…

Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck

DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Active Pharmaceutical Ingredient Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028:…

XETR : DIVIDEND/INTEREST INFORMATION - 05.01.2023 - US1101221083

Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird cum Dividende/Zinsen gehandelt am 04.01.2023 und ex Dividende/Zinsen am 05.01.2023 The instrument BRM…

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Copy_Lotte Biologics completes acqusition of BMS drug plant

Lotte Group has completed a $160 million acquisition of US drug firm Bristol Myers Squibb, the group’s drug manufacturing unit…

Drugmakers Spent Freely in 2022 to Protect Revenue

Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics....…

Bristol Myers Squibb (BMY) Stock Moves -0.85%: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $71.99, moving -0.85% from the previous trading session....…

QIX Deutschland: BMW treibt eigene Elektrostrategie weiter voran und EVOTEC baut Neurologie-Kooperation mit Bristol-Myers Squibb aus

Angesicht fehlender Konjunkturdaten und Unternehmensnachrichten zeigt sich der QIX Deutschland am Mittwoch kaum verändert bei 13.395 Punkten....…

Bristol Myers Squibb (BMY) Stock Moves -0.38%: What You Should Know

Bristol Myers Squibb (BMY) closed at $72.61 in the latest trading session, marking a -0.38% move from the prior day....…

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be…

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Stock Moves -0.45%: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $73.16, moving -0.45% from the previous trading session....…

Evotec to Receive $26 Mln in Expanded Bristol Myers Squibb Collaboration

Evotec to Receive $26 Mln in Expanded Bristol Myers Squibb Collaboration...…

Evotec to get $26M from Bristol Myers as drug projects added under neuroscience pact

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Evotec: Top News verpuffen – die Details

Das Hamburger Biotechunternehmen Evotec hat weitere Fortschritte in seiner Neurologie-Kooperation mit dem US-Pharmaunternehmen Bristol-Myers Squibb erreicht. So soll die Partnerschaft…

Evotec erreicht weitere Fortschritte in Neurologie-Kooperation

FRANKFURT (Dow Jones)--Evotec hat "weitere erhebliche Fortschritte" in der Neurologie-Kooperation mit Bristol Myers Squibb erreicht. Wie die Evotec SE mitteilte,…

Media News: Evotec SE

Evotec erreicht weiteren Fortschritt in Neurologie-Kooperation mit Bristol Myers Squibb...…

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that…

Seeq Achieves AWS Life Sciences Competency Status

The designation recognizes Seeqs expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers…

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $78.89, moving +0.08% from the previous trading session....…

The Zacks Analyst Blog Highlights Merck, Bristol-Myers Squibb and Deere

Merck, Bristol-Myers Squibb and Deere are included in this Analyst Blog....…

Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere

Todays Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and…

Lyfebulb Announces Finalists for the 2022 Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation,…

Bristol-Myers Squibb Company raises quarterly dividend by 5.6% to $0.57/share

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Outlook on the Psoriatic Arthritis Treatment Global Market to 2027 - Players Include AbbVie, Johnson & Johnson, UCB, Amgen and Bristol-Myers Squibb

DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has…

Envisagenics, Bristol Myers Squibb Enter Research Collaboration

NEW YORK CITY (dpa-AFX) - Envisagenics announced a research collaboration agreement with Bristol Myers Squibb (BMY). The collaboration will leverage…

uniQure says Bristol Myers to terminate licensing deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate LVGN7409 in Combination with Nivolumab in Non-Small Cell Lung Cancer Patients

LVGN7409 is a next generation CD40 agonistic antibody; Nivolumab is a PD-1 checkpoint inhibitor; docetaxel is an anti-tubulin chemotherapy agent…

dpa-AFX ProFeed